A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease

Kevin M Elias1, Antonio Braga2, Neil S Horowitz1

  • 1New England Trophoblastic Disease Centre, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02446, MA, USA.

The Lancet. Oncology
|October 8, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K